tradingkey.logo
tradingkey.logo
検索

Intuitive Surgical Inc

ISRG
ウォッチリストに追加
366.700USD
-3.130-0.85%
終値 09-04 16:00ET
129.72B時価総額
43.83直近12ヶ月PER

詳細情報 Intuitive Surgical Inc 企業名

Intuitive Surgical, Inc. develops, manufactures, and markets da Vinci surgical systems and the Ion endoluminal system. The Company specializes in invasive care and robotic-assisted surgery. Its technologies include the da Vinci surgical systems and the Ion endoluminal system. The da Vinci surgical system is designed to enable surgeons to perform a range of surgical procedures within its targeted general surgery, urologic, gynecologic, cardiothoracic, and head and neck specialties and consists of a surgeon's console or consoles, a patient-side cart, and a high-performance vision system. The Ion endoluminal system is a flexible, robotic-assisted, catheter-based platform for which the cleared indication is minimally invasive biopsies in the lung and consists of a system cart, a controller, a catheter, and a vision probe. Its Ion system extends its commercial offering beyond surgery into diagnostic and endoluminal procedures.

Intuitive Surgical Inc プロフィール

企業コードISRG
会社名Intuitive Surgical Inc
上場日Jun 13, 2000
最高経営責任者「CEO」Rosa (David J)
従業員数15638
証券種類Ordinary Share
決算期末Jun 13
本社所在地1020 Kifer Road
都市SUNNYVALE
証券取引所NASDAQ OMX - NASDAQ BASIC
United States of America
郵便番号94086
電話番号14085232100
ウェブサイトhttps://www.intuitive.com/en-us/about-us/company
企業コードISRG
上場日Jun 13, 2000
最高経営責任者「CEO」Rosa (David J)

Intuitive Surgical Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Gary S. Guthart, Ph.D.
Dr. Gary S. Guthart, Ph.D.
Executive Chairman of the Board
Executive Chairman of the Board
1.29M
+1.56%
Dr. Gary S. Guthart, Ph.D.
Dr. Gary S. Guthart, Ph.D.
Executive Chairman of the Board
Executive Chairman of the Board
1.29M
+1.56%
Dr. Gary S. Guthart, Ph.D.
Dr. Gary S. Guthart, Ph.D.
Executive Chairman of the Board
Executive Chairman of the Board
1.29M
+1.56%
Mr. David J. Rosa
Mr. David J. Rosa
Chief Executive Officer, Director
Chief Executive Officer, Director
246.80K
+0.39%
Mr. David J. Rosa
Mr. David J. Rosa
Chief Executive Officer, Director
Chief Executive Officer, Director
246.80K
+0.39%
Mr. David J. Rosa
Mr. David J. Rosa
Chief Executive Officer, Director
Chief Executive Officer, Director
246.80K
+0.39%
Dr. Craig H. Barratt, Ph.D.
Dr. Craig H. Barratt, Ph.D.
Lead Independent Director
Lead Independent Director
27.20K
+3.83%
Dr. Craig H. Barratt, Ph.D.
Dr. Craig H. Barratt, Ph.D.
Lead Independent Director
Lead Independent Director
27.20K
+3.83%
Dr. Craig H. Barratt, Ph.D.
Dr. Craig H. Barratt, Ph.D.
Lead Independent Director
Lead Independent Director
27.20K
+3.83%
Johnson (Amal M)
Johnson (Amal M)
Independent Director
Independent Director
13.54K
+3.92%
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Gary S. Guthart, Ph.D.
Dr. Gary S. Guthart, Ph.D.
Executive Chairman of the Board
Executive Chairman of the Board
1.29M
+1.56%
Dr. Gary S. Guthart, Ph.D.
Dr. Gary S. Guthart, Ph.D.
Executive Chairman of the Board
Executive Chairman of the Board
1.29M
+1.56%
Dr. Gary S. Guthart, Ph.D.
Dr. Gary S. Guthart, Ph.D.
Executive Chairman of the Board
Executive Chairman of the Board
1.29M
+1.56%
Mr. David J. Rosa
Mr. David J. Rosa
Chief Executive Officer, Director
Chief Executive Officer, Director
246.80K
+0.39%
Mr. David J. Rosa
Mr. David J. Rosa
Chief Executive Officer, Director
Chief Executive Officer, Director
246.80K
+0.39%
Mr. David J. Rosa
Mr. David J. Rosa
Chief Executive Officer, Director
Chief Executive Officer, Director
246.80K
+0.39%

よくある質問

Intuitive Surgical Incの上位5名の株主は誰ですか?

Intuitive Surgical Incの上位5名の株主は以下のとおりです。Dr. Gary S. Guthart, Ph.D.

Intuitive Surgical Inc(ISRG)の株式を保有している機関の数はいくつですか?

2026Q1時点で、Intuitive Surgical Incの株式を保有している機関は3941社あり、保有株式の総市場価値は約316.11Mで、全体の89.25%を占めています。2025Q4と比較して、機関の持ち株は-2709007.00増加しています。

Intuitive Surgical Incの最大の収益源は何ですか?

2026Q1において、Instruments and accessories部門がIntuitive Surgical Incにとって最大の収益を生み出しており、その金額は1.73Bで、全収益の59.98%を占めています。
tradingkey.logo
リスク告知:当社ウェブサイト及びモバイルアプリは特定の投資商品に関する一般的な情報のみを提供しており、Finsightsは金融アドバイスや投資商品の推奨を行うものではありません。本情報の提供をもってFinsightsが投資助言を行っていると解釈されることはありません。
投資商品には元本割れを含む重大なリスクが伴い、全ての投資家に適するものではありません。なお、過去の運用実績は将来の成果を保証するものではありません。
Finsightsは、第三者広告主または提携先が当社ウェブサイト・モバイルアプリ上に広告を掲載することを許可する場合があり、これら広告主から広告への反応に基づく報酬を受けることがあります。
© 著作権: FINSIGHTS MEDIA PTE. LTD. 無断複写・転載を禁じます。